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A 
study published in this issue  of The Journal of Experi- 
mental Medicine, sheds new light on the behavior and 
functions of dendritic cells  (DC) which play a pivotal role 
in initiation of T  and T-dependent immune responses (1). 
The study is important in at least three respects: first, it pro- 
vides information on recruitment of DC progenitors to a 
non-lymphoid  tissue,  the  liver;  second,  it  provides  evi- 
dence that DC have transient phagocytic activity for partic- 
ulates in vivo, a prerequisite for induction of immune re- 
sponses against bacteria for example; and third, it defines a 
migration pathway for DC, that have acquired particulates 
from the blood, from the liver to draining nodes. 
To put this paper (1) into context it is necessary to sum- 
marize the  general  consensus  of understanding  about the 
DC  lineage that has emerged over the past decade or so. 
DC  progenitors that  originate from the  bone marrow of 
adult mammals enter the blood and seed non-lymphoid tis- 
sues, where they develop into a stage of DC (sometimes re- 
ferred to as immature DC) with optimal capabilities for an- 
tigen  uptake  and  processing,  MHC  production,  and  the 
formation of foreign peptide-MHC  complexes ("process- 
ing" DC). These cells are localized in epitheha, such as skin 
epidermis, gut, genito-urinary tract, and the lung and air- 
ways,  and  in  the  interstitial  spaces  of many solid  organs 
such  as  heart and  kidney.  Inflammatory mediators  (cyto- 
kines and other agents)  then promote their maturation and 
migration out of non-lymphoid tissues  into blood and/or 
afferent lymph. These migratory cells enter secondary lym- 
phoid tissues  where they express newly acquired capabili- 
ties for the initiation of primary T  and T-dependent im- 
mune responses, at least in part due to their expression of 
costimulatory molecules and synthesis of certain cytokines 
such as IL-12 ("presenting" DC,  sometimes referred to as 
mature DC). Migratory DC,  travelling between non-lym- 
phoid and secondary lymphoid tissues,  are generally con- 
sidered to be undergoing "maturation" from the processing 
to presenting stages, although maturation is likely to be ini- 
tiated within non-lymphoid tissues and to continue within 
secondary lymphoid tissues. 
At the  outset,  it is therefore convenient to define four 
stages  of the  DC  lineage in  distinct anatomical compart- 
ments: DC progenitors in bone marrow and blood; imma- 
ture  DC  at  the  processing  stage  in  peripheral  non-lym- 
phoid organs; migratory DC in the process of maturation 
in afferent lymph and blood;  and mature DC  at the pre- 
senting stage in secondary lymphoid tissues (2-4). Arguably 
this view is an over-simplification. For example, DC pro- 
genitors  may  enter  secondary  lymphoid  tissues  directly; 
some DC in non-lymphoid tissues may possess a degree of 
costimulatory activity; some DC  in lymphoid tissues  may 
be capable of antigen uptake and processing to some ex- 
tent; and DC in thymus may play a role in the induction of 
T  cell tolerance to self peptide-MHC complexes. Never- 
theless,  it provides a  useful framework for understanding 
how, where, and when DC regulate the induction of pri- 
mary immune  responses.  It is  also  important to  add  that 
once antigen-specific T  cells have been activated by DC, 
the activated T  cells appear not to require the specialized 
costimulatory signals that are delivered by DC, and may re- 
spond to other types of antigen-presenting cell expressing 
the peptide-MHC  complexes for which  they are specific 
(2, 3). 
DCProgenitors.  A  major  advance  over  the  past  few 
years has been the ability to grow DC from bone marrow 
and blood progenitors and to control production of differ- 
ent  stages  of the lineage in vitro.  For example,  develop- 
ment of immature human DC  is promoted by culture of 
bone marrow or blood progenitors in the presence of GM- 
CSF and IL-4 (5, 6), and further maturation can be induced 
by subsequent exposure to TNF-ot or CD40 ligand, or to 
other agents such as bacterial lipopolysaccharide (LPS)  (7). 
Inclusion  of stem  cell  factor  (c-kit ligand)  increases  cell 
yields and permits discrete colonies of DC to be grown in 
semi-solid culture systems (8).  Nevertheless the identifica- 
tion  of bona  fide  DC  progenitors  remains  difficult:  DC 
may share a committed stem cell with monocytes and neu- 
trophils (9); or with T  cells, B  cells and NK cells  (10);  or 
indeed they may differentiate from monocytes. However, 
it is possible to generate mouse DC from presumptive liver 
progenitors cultured in the presence of GM-CSF, further 
maturation being promoted by the presence of type-1 col- 
lagen  in  vitro  (11);  these  progenitors may be  capable  of 
seeding  secondary  lymphoid  tissues,  and  possibly  some 
non-lymphoid tissues,  following liver allografting in vivo 
(12). 
What  stimuli  recruit  DC  progenitors  into  the  tissues? 
Regarding epithelia, there is evidence that intradermal ad- 
ministration of GM-CSF leads to an increase in numbers of 
DC within the dermis of human skin,  which may be the 
precursors to  epidermal Langerhans cells  (LC, the DC  of 
skin  epidermis)  (13).  In addition,  GM-CSF  produced by 
normal and inflamed tissues,  and some carcinomas, within 
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(14).  Additional infornlation comes from studies showing 
that DC are recruited into the epidermis of airways of rats 
in response to LPS delivered in aerosol form to the lungs, 
and that the kinetics of the transient influx of DC  mirror 
those of the neutrophil component of the acute inflamma- 
tory response (15).  Furthermore, DC progenitors are rap- 
idly recruited into the airway epithelium of rats after inha- 
lation  of Moraxella  catarrhalis organisms  (which  induce  an 
inflammatory tracheitis in humans); remarkably, in this sys- 
tem the initial wave of DC arrives in advance of the neu- 
trophil influx to the tissues (16).  In the case of solid organs, 
systemic administration  of LPS to mice promotes the  re- 
cruitment of DC  progenitors into  heart  and  kidney and 
probably into other non-lymphoid tissues, presumably due 
to the cytokines elicited by this agent (17). 
The paper of Matsuno et al.  (1) now presents data indi- 
cating  that  DC  are  recruited into  the  liver  (and  possibly 
spleen) in response to a bolus of  particulates delivered intra- 
venously. However, in contrast to the agents studied above 
(cytokines, LPS, and bacteria; 13-17), the particles used in 
the present study (1; carbon, latex microspheres) are immu- 
nologically inert (although colloidal carbon fixes C3). One 
interpretation is that DC  are recruited to the liver in re- 
sponse to cytokines synthesized by Kupffer cells that have 
phagocytosed particles.  If so,  this  adds  a  further level  of 
complexity to macrophage regulation of DC migration and 
function since,  for example,  it has  also  been shown  that 
macrophages  in  lung  may maintain  DC  at  an  immature, 
processing stage in situ (18). 
Non-lymphoid Dendritic Cells.  Non-lymphoid DC  resi- 
dent within epithelia and the interstitial spaces of solid or- 
gans are ideally placed to perform a "sentinel" function for 
the  immune  system, with  the  capacity to  internalize  and 
process foreign antigens that gain access to these sites before 
migration into  secondary lymphoid tissues  for the induc- 
tion  of immune  responses.  Important  insights  into  the 
properties  of non-lymphoid  DC  came  from  studies  of 
Langerlians cells (LC), the DC of skin which are normally 
resident  within  the  epidermis  (2).  It  was  shown  that 
freshly-isolated LC develop into cells resembling DC  iso- 
lated from lymphoid tissues during culture in the presence 
of GM-CSF,  normally produced by keratinocytes within 
cultures of epidermal cell suspensions. During this process 
of"maturation," which can be further modulated by TNF-ot 
for example, the cells undergo phenotypic remodelling ac- 
companied by profound changes in function. 
Freshly isolated LC express plasma membrane molecules 
such as Fc receptors, complement receptors, and mannose 
receptors, some of which appear to target antigens into the 
cellular antigen processing pathways. The cells are capable 
of pinocytosis and processing of soluble antigens which are 
subsequently expressed as peptide-MHC complexes at the 
cell surface.  (Cells  grown from human blood progenitors 
and presumably DC in tissues are also capable of macropi- 
nocytosis, which provides an additional route for uptake of 
soluble  molecules;  7,  19.)  However,  the  freshly isolated 
cells have little capacity to initiate primary in vitro immune 
1288  Commentary 
responses. During maturation in culture, Fc receptors and 
probably  mannose  receptors  are  downregulated  together 
with the capacity to process soluble native antigens. These 
events are accompanied by the disappearance of acidic in- 
tracellular compartments that are associated with processing 
of exogenous antigens and a cessation of biosynthesis of in- 
variant chain and MHC class II molecules, which are syn- 
thesized at a high rate in freshly isolated LC presumably for 
loading  with  antigenic  peptides.  The  maturing  cells  be- 
come capable of triggering T  cell activation, in part due to 
new or increased expression of costimulatory molecules in- 
cluding CD40, CD80 (B7-1) and CD86 (B7-2), the ligands 
for CD40 ligand, and CD28  /  CTLA-4 on T  cells (2, 3). 
But this is only part of the story. 
For DC  to  initiate responses against  pathogens such  as 
bacteria  and  yeasts,  it  would  seem  essential  for them  to 
have phagocytic activity. And yet the general consensus is 
that DC in lymphoid tissues are, by and large, non-phago- 
cytic. A resolution to this problem was offered when it was 
shown that freshly isolated LC can phagocytose a variety of 
particles, at least in vitro, and that this capacity is lost when 
the cells mature in culture (20). Particles that can be phago- 
cytosed by freshly isolated mouse LC include latex micro- 
spheres  (0.5  to 3 micron in diameter), zymosan (probably 
via mannose receptors), and Saccharomyces cerevisiae, Staphylo- 
coccus aureus,  and  Corynebacterium  parvis  organisms.  How- 
ever, there are marked quantitative and qualitative differ- 
ences between the phagocytic capabilities  of freshly isolated 
LC and macrophages. For example, LC phagocytose rela- 
tively few particles whereas macrophages internalize many, 
and mouse LC fail  to ingest antibody- and  complement- 
opsonized erythrocytes whereas these cells are readily phago- 
cytosed by macrophages (20). Presumably, these differences 
reflect the specialized capacities of these cell types for anti- 
gen presentation and initiation of immune responses (DC) 
versus scavenging and clearance of  particulates  (macrophages). 
LC also appear to phagocytose Leishmania organisms and 
can present Leishmania antigens to antigen-specific, primed 
T  cells (21). Further, it was demonstrated that DC cultured 
from mouse  bone  marrow  in  the  presence  of GM-CSF 
possess transient phagocytic activity for mycobacteria, and 
that such antigen-pulsed DC can present mycobacterial an- 
tigens  to  primed T  cells  (22).  Further evidence that  DC 
have phagocytic activity comes from studies showing that 
LC  within  vaginal  epithelium  of mice  contain  apoptotic 
epithelial cells (23),  and that following intravenous admin- 
istration  of allogeneic lympliocytes to rats  these  (possibly 
apoptotic) lymphocytes are detectable within interdigitat- 
ing cells (IDC) of T  areas of spleen (24), although it seems 
likely that phagocytosis occurred elsewhere before translo- 
cation of DC to these areas. 
Studies  of DC  isolated  from  mouse  heart  and  kidney 
have revealed similarities  between interstitial DC  and LC 
of skin (25). For example, freshly isolated cells are unable to 
initiate primary in vitro responses, but  this  activity is  ac- 
quired after overnight culture of bulk parenchymal cell sus- 
pensions, which presumably elaborate the cytokines neces- 
sary for maturation. Freshly isolated DC from both organs are able  to phagocytose latex microspheres,  although this 
capacity is not lost after overnight culture which may re- 
flect a paucity of cytokines necessary for complete matura- 
tion in this time period.  The study of Matsuno  et al.  (1) 
now provides direct evidence that intravenously-adminis- 
tered  particulates  can  be  phagocytosed  in  vivo  by  DC 
within the liver (and/or spleen). This activity is transiently 
expressed by the cells, most likely between the time of re- 
cruitment of DC progenitors into the liver (and/or spleen) 
and migration of the more mature cells, which exhibit co- 
stimulatory activity in vitro, into hepatic lymph. 
Migratory Dendritic Cells.  As a general rule, DC migrate 
from epithelia perhaps exclusively via afferent lymph into 
regional  nodes,  and  from  solid  organs  via  both  afferent 
lymph and blood into regional nodes and spleen, respec- 
tively (see below). Within afferent lymph, DC are often re- 
ferred to as "veiled cells" because of their distinctive cytol- 
ogy, namely the presence of sheet-like lamellipodiae. Early 
experiments (reviewed in reference 26) demonstrated a flux 
of DC in afferent lymphatics draining normal skin that was 
considerably enhanced after the application of contact sen- 
sitizing agents.  Subsequent studies of  the behavior of  Langer- 
hans cells in mouse skin transplants  and explants revealed that 
epidermal Langerhans cells migrate into dermal lymphatics 
and thence to regional nodes, and that they begin to ma- 
ture before or during their exit from the skin (reference 27 
and  Liddington,  M.I.,  and  J.M.  Austyn,  manuscript  in 
preparation); similar studies have been performed with ex- 
plants of human skin (28).  Experiments using DC isolated 
from afferent lymph draining skin of larger animal species 
such as sheep (29) have also demonstrated that the migrat- 
ing  cells  can present  antigens  derived from local sites  to 
primed T  cells and can initiate primary immune responses 
in vitro. 
Studies have also been performed of veiled cells draining 
from gut epithehum into afferent lymphatics. In small ani- 
mals, such as rats, an important approach has been to surgi- 
cally excise the mesenteric lymph nodes (mesenteric lym- 
phadenectomy), permit re-anastomosis of lymphatics,  and 
cannulate  the  thoracic  duct.  The DC  collected represent 
cells  that  are normally trafficking from gut to mesenteric 
nodes, and their output in pseudo-afferent lymph is consid- 
erably increased following systemic administration of LPS 
(30).  The cells are non-phagocytic in vitro, but often con- 
tain  Feulgen-positive inclusions,  indicative of endocytosis 
of DNA-containing material at some point in the past. Fol- 
lowing administration of soluble antigens by oral feeding or 
intraintestinal injection, these DC can stimulate T  cells that 
have been primed to  the  corresponding antigen in vitro, 
and can prime T  cells in vivo after footpad injection into 
naive  recipients  (31).  By  autoradiography  it  was  shown 
that, following injection into the rat footpad, such DC mi- 
grate to popliteal nodes and home to paracortical (T) areas 
(32).  From these and other studies, it seems clear that DC 
in epithelia ultimately migrate into regional lymph nodes to 
initiate immune responses. 
In the case of interstitial DC of solid organs, there is an 
additional migratory route for the cells via the blood to the 
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spleen. This was revealed in studies tracing the migration of 
DC that were isolated from mouse spleens and injected in- 
travenously (33,  34). The cells, tagged with a radiolabel or 
fluorochromes,  were  found  to  enter  the  spleen  and  to 
home to specific regions. Using a fully vascularized cardiac 
allograft model in mice, DC were observed to leave the or- 
gan and also  to  enter recipient spleens,  where they again 
localized in particular compartments (35).  Presumably, in- 
terstitial DC  that acquire antigens in solid organs can also 
migrate via blood (as well as via afferent lymph) for initia- 
tion  of responses.  In  addition  to  migration  of DC  from 
blood to spleen, the cells were found to enter livers of eu- 
thymic mice (33).  In nude mice, however, homing to the 
spleen  did  not  occur unless  the  mice were  reconstituted 
with T cells; instead, cells that would normally home to the 
spleen quantitatively entered the liver. Furthermore, veiled 
cells  obtained  from  central  lymph  of  mesenteric  lym- 
phadenectomized rats were shown to migrate into the liver 
and thence to celiac nodes after intravenous injection (32). 
The significance of these observations was not fully appre- 
ciated in these earlier studies but becomes apparent from 
the study ofMatsuno et al. (1) (see below). 
What stimuli promote migration of DC from non-lym- 
phoid tissues? It seems likely that cytokines generated dur- 
ing  inflammatory responses  promote  the  maturation  and 
migration of DC  to regional lymph nodes.  For example, 
intradermal injection of murine IL-113 (but not IL-lot) or 
of TNF-ot into mouse skin leads to a reduction in numbers 
of epidermal LC, and both cytokines are elicited during ex- 
posure to contact allergens  (36,  37).  In addition, systemic 
administration  of LPS  induces  a  profound loss  of MHC 
class II+  cells  from mouse heart and kidney, most likely 
due to migration,  and qualitatively similar effects are ob- 
served following administration of human TNF-ot or IL- 
10t (38).  The increased output of cells from rat gut in re- 
sponse to systemic LPS, but not the loss of interstitial DC 
from mouse heart and kidney, can be ablated by pretreat- 
ment  with  neutralizing  anti-TNF  antibodies  (30,  38). 
Hence these cytokines may induce,  directly or indirectly, 
the  migration  of DC  from  sohd  organs,  although  LPS 
could conceivably act directly on the cells  (e.g., reference 
7). The capacity of LPS to promote migration of immature 
DC (presumably to secondary lymphoid tissues) and to re- 
cruit a wave of DC progenitors to the same tissues (17) may 
explain the adjuvant properties of this agent. 
Physiologically,  the  migratory  routes  noted  above  are 
likely required for initiation of immune responses to solu- 
ble or particulate antigens that have gained access to the ep- 
ithelia  or interstitial spaces  and been internalized by DC. 
The paper of Matsuno et al.  (1) now provides information 
on a probable specialized role of DC in the liver for initia- 
tion  of responses  to  antigens  acquired  directly from  the 
blood circulation. In particular,  evidence is presented that 
intravenously  administered  particulates  can  be  phagocy- 
tosed by DC within the liver before migration of these cells 
via hepatic lymph to  regional nodes,  and most likely via 
blood to spleen. 
Lymphoid Dendritic Cells.  It seems possible that DC are localized within distinct compartments of lymphoid tissues 
during different stages of immune response induction. For 
example,  DC  migrating from  allografts  appear  to  be  re- 
tarded in B areas (peripheral white pulp) before moving to 
T  areas  (central white pulp) of spleen (35,  17). In contrast, 
following intravenous administration, syngeneic DC appear 
to bind within marginal zone of spleen, and then to home, 
respectively, to red pulp  and T  areas  by 3  and 24 h  later 
(34). In an analogous manner, ifsyngeneic DC are injected 
into the footpad of  mice, they home from subcapsular sinus 
to interfollicular areas  and ultimately into paracortical (T) 
areas (32, 34). The data ofMatsuno et al. (1) reinforce these 
observations, in tl~at they demonstrate homing of particle- 
laden DC from liver to discrete compartments of the celiac 
nodes and probably spleen. 
New Insights.  An  important marker  of rat  DC  that  is 
central to the present study (1) is the OX62 antigen. Within 
secondary lymphoid tissues,  OX62+  cells  are  present  in 
red pulp and T  areas  of the central white pulp  of spleen, 
and in the  subcapsular sinus,  medulla,  and T  areas  of the 
paracortex  of peripheral  lymph  nodes;  OX62+  cells  are 
also  present  in  some  non-lymphoid tissues  including  the 
liver (39). It seems reasonable at the present time to assume 
that OX62 is stably expressed by DC and is not expressed 
by other non-lymphoid cells. 
The  system  used  (1)  is  analogous  to  mesenteric  lym- 
phadenectomy of rats for studies of DC migrating from the 
gut to the mesenteric lymph nodes.  Namely, celiac nodes 
are excised, lymphatics are allowed to re-anastomose, and 
the thoracic duct in cannulated (40). Following intravenous 
administration of carbon and latex microspheres, many of 
the  OX62+  DC  that would normally migrate in afferent 
lymph are found to  be laden with particles.  Importantly, 
particle-laden OX62+  cells are not evident following me- 
senteric lymphadenectomy, indicating  a  likely specialized 
role for at least some DC in liver in the acquisition of  parti- 
cles from the blood circulation, and in the initiation of re- 
sponses  to blood-borne antigens at least in part within the 
celiac nodes. 
It seems probable that, following intravenous administra- 
tion of particles, DC progenitors are recruited to the liver 
where they may internalize particulates. In normal rat liver, 
OX62+  cells  are localized predominantly in portal areas, 
very few being present in sinusoids  or around the central 
vein.  Within  1  h  of administration  of particles,  particle- 
laden OX62+  cells accumulate in the  sinusoids  and their 
numbers increase and plateau between 6 h and 2 d later. A 
close  association  between  the  OX62+  cells  and  Kupffer 
cells is  often observed, raising the possibility that Kupffer 
cells  that  have phagocytosed particles elaborate  cytokines 
that  recruit DC  progenitors from the  blood and possibly 
promote their development and further maturation;  alter- 
natively, the DC could originate from preexisting progenitors 
within the liver (11).  Certainly, many of the antigen-laden 
OX62+  cells  that enter the  hepatic lymph have recently 
divided, their cytology is relatively immature compared to 
that of DC in normal lymph, and the output of these cells 
into the lymph is over and above that of DC lacking parti- 
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cles (the latter possibly originating from distinct sites such as 
biliary epithelium; see below). During or after the phago- 
cytic event, the OX62 +  cells appear to undergo a matura- 
tion step before leaving the liver, since cells isolated from 
the lymph cannot phagocytose additional particles but can 
initiate primary immune responses in vitro. 
In normal mouse liver, many cells around the bile duct 
in portal areas  can be labeled with N418,  a DC-restricted 
antigen which, like OX62 (39) appears to be a member of 
the integrin family of adhesins (41).  These cells do not in- 
ternalize carbon that is administered intravenously (41) sug- 
gesting that DC in the biliary epithelial system, which sub- 
sequently enter hepatic lymph, may be specialized to take 
up antigens within the epithelium itsels  This pool of DC 
may thus be  distinct from the  DC  that  appear to  be  re- 
cruited  to  the  sinusoids  to  internalize  particles  from  the 
blood (1). 
Migration of particle-laden DC from the liver occurs in 
hepatic lymph, and probably the blood. Within the liver, 
particle-laden OX62+  cells  are present in portal  areas  at 
6 h, and in central (hepatic vein) areas at 18 h after admin- 
istration of particles, and can be detected in these sites for at 
least 2 d. This suggests  that the cells translocate from sinu- 
soids  into these areas before entry to the descending lym- 
phatics and migration to celiac nodes, and possibly also into 
ascending lymphatics. Particle-laden OX62 +  cells first ap- 
pear in the marginal sinus  and interfollicular areas of celiac 
lymph nodes at 6 h, and appear to home to paracortical (T) 
areas by 18 h, consistent with earlier reports (32, 34). 
Particle-laden OX62+  cells probably also migrate from 
the liver to the spleen via the blood. The cells are detected 
in splenic marginal zone and red pulp from 1 h to 2 d, and 
appear to home to white pulp  18 h  after administration of 
particles, reminiscent of earlier observations (34). An alter- 
native explanation for particle-laden OX62+  cells in spleen 
is that DC progenitors are recruited to the spleen before in- 
ternalization of particles;  for example, splenic  red pulp mac- 
rophages,  which  avidly ingest  intravenously administered 
carbon particles (41) could conceivably elaborate cytokines 
to recruit DC to the red pulp. An additional, perhaps less 
likely,  possibility  is  that  particle-laden  cells  may  migrate 
from the  spleen  to  the  liver and  thence  to  celiac nodes. 
Shaving with Occum's razor, however, the former hypoth- 
esis is perhaps to be preferred at the present time. 
In  summary,  we  now  appear  to  have  three  routes  by 
which DC can initiate responses to antigens from different 
anatomical compartments: (a) DC in epithelia such as skin 
and  gut  acquire local antigens  and  migrate  via lymph  to 
nodes;  (b) DC in interstitial spaces  of organs such as heart 
and kidney acquire local antigens and migrate via lymph to 
nodes, and via blood to spleen; and  (c) a subset of DC in 
liver  acquires  antigens  from  the  blood  and  migrates  via 
lymph to regional nodes, and probably via blood to spleen. 
The present  study  (1),  by  approaching  the  liver and  by 
demonstrating the recruitment and phagocytic capacity of 
DC  following particle administration,  has  helped to  close 
significant gaps  in our understanding of the behavior and 
functions of the DC lineage. Address correspondence to Jonathan Austyn, Nuffield Department of Surgery, University of Oxford, John 
Radcliffe Hospital, Headington, Oxford OX3 9DU, UK. 
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